09-016
Showing 26 - 50 of 2,479
Inferior Turbinate Hypertrophy Trial in Mansoura (Medial Flap Coblation Turbinoplasty, Submucous Resection)
Completed
- Inferior Turbinate Hypertrophy
- Medial Flap Coblation Turbinoplasty
- Submucous Resection
-
Mansoura, EgyptMansoura University faculty of Medicine
Feb 21, 2023
Primary Open-angle Glaucoma, Cataract Trial in United States (CyPass Micro-Stent implanted with CyPass 241-S applier)
Terminated
- Primary Open-angle Glaucoma
- Cataract
- CyPass Micro-Stent implanted with CyPass 241-S applier
- Cataract surgery
-
Phoenix, Arizona
- +19 more
Aug 24, 2022
Ulcerative Colitis Trial (Empagliflozin, conventional treatment)
Not yet recruiting
- Ulcerative Colitis
- Empagliflozin
- conventional treatment
- (no location specified)
Nov 9, 2022
Visual To Compare the Visual Outcome Between AcrySof™ IQ Vivity™ and TECNIS Synergy™ Intraocular Lens (Model ZFR00V ) Trial in
Recruiting
- Visual To Compare the Visual Outcome Between AcrySof™ IQ Vivity™ and TECNIS Synergy™ Intraocular Lens (Model ZFR00V )
- IOL implantation
-
Cairo, EgyptCairo University
Dec 11, 2022
Obesity, Overweight Trial in Peshawar (High Protein Meal at Cold Temperature, High Protein Meal at Warm Temperarute, High
Recruiting
- Obesity, Overweight
- High Protein Meal at Cold Temperature
- +8 more
-
Peshawar, KPK, PakistanKhyber Medical University
Apr 7, 2023
Cardiovascular Disease in Asthma and Eosinophil Subtypes and
Not yet recruiting
- Asthma
- Cardiovascular Diseases
- Asthma and cardiovascular disease
- (no location specified)
Oct 18, 2022
Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)
Recruiting
- Peripheral T Cell Lymphoma
- Linperlisib in combined with Chidamide
-
Beijing, Beijing/China, China
- +1 more
Oct 9, 2023
Rhythmic Handwriting Deficits and General Rhythmic Abilities in
Not yet recruiting
- Developmental Coordination Disorder
-
Montpellier, FranceHôpital La Colombière - CHU de Montpellier
Aug 24, 2023
AAV2hAQP1 for Radiation Induced Xerostomia
Enrolling by invitation
- Radiation-induced Xerostomia
-
Stanford, California
- +3 more
Dec 22, 2022
COVID-19 Trial in Beijing, Shanghai (Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg), Placebo)
Completed
- COVID-19
- Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)
- Placebo
-
Beijing, China
- +1 more
Jul 14, 2022
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Rectal Cancer, Comorbidities and Coexisting Conditions, Inoperable Disease Trial in Montreal (External beam radiotherapy +
Recruiting
- Rectal Cancer
- +3 more
- External beam radiotherapy + Endorectal brachytherapy
-
Montreal, Quebec, CanadaJewish General Hospital
Oct 25, 2022
Psychological Symptoms in Fibromyalgia Patients Trial (Repitetive transcranial magnetic stimulation)
Not yet recruiting
- Psychological Symptoms in Fibromyalgia Patients
- Repitetive transcranial magnetic stimulation
- (no location specified)
Sep 25, 2022
Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant
Not yet recruiting
- Breast Cancer
- +5 more
- Breast Surgery (BCS or mastectomy) with TAD/SNB
- Adjuvant Radiation Therapy
- (no location specified)
Oct 24, 2023
Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)
Recruiting
- Langerhans Cell Histiocytosis of Bone
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Oct 15, 2023
Pediatric Acute Respiratory Distress Syndrome (PARDS), Acute Respiratory Failure, Acute Respiratory Distress Syndrome Trial in
Not yet recruiting
- Pediatric Acute Respiratory Distress Syndrome (PARDS)
- +2 more
- Fast method
- Conventional method
-
Aydın, Turkey
- +3 more
Sep 20, 2023
CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T
Recruiting
- CAR T-Cell Therapy
- HEC-016(0.5×10^6 CAR-T Cells)
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen Luohu Hospital
Mar 3, 2022
Genito-Pelvic Pain/Penetration Disorder Trial in Lahore (soft tissue release, vaginal dilators)
Recruiting
- Genito-Pelvic Pain/Penetration Disorder
- soft tissue release
- vaginal dilators
-
Lahore, Punjab, PakistanLahore general hospital
May 4, 2023
Kyphosis Trial (Exercises)
Not yet recruiting
- Kyphosis
- Exercises
- (no location specified)
Oct 9, 2023
Acute Ischemic Stroke, Cerebral Edema Trial in Beijing (SIM1910-09, Placebo)
Recruiting
- Acute Ischemic Stroke
- Cerebral Edema
- SIM1910-09
- Placebo
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jan 7, 2022
Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Pembrolizumab
- +2 more
-
Duarte, California
- +39 more
Jul 29, 2022
